drugset / Trial / NCT00855660

Effect of Riociguat on Bone Metabolism

NCT00855660

Phase 1 Completed 17 enrolled Bayer
RandomizedCrossoverTriple-blindTreatment

Summary

Investigation of the effect of Riociguat, administered as 2.5 mg IR-tablets TID over 14 days, on bone metabolism.

Timeline

Start
2009-03
Primary completion
2009-12
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riociguat Other / unclassified 2.5 mg

Indications

No indication recorded.